Takuji Yamauchi Selected Research

5- ((1- (2,6- dichlorobenzyl)piperidin- 4- yl)methoxy)quinazoline- 2,4- diamine

1/2019

[Exploration of novel therapeutic targets in acute myeloid leukemia via genome-wide CRISPR screening].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takuji Yamauchi Research Topics

Disease

5	Leukemia 01/2022 - 01/2016
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2009
2	Infections 08/2022 - 01/2022
2	Cytomegalovirus Infections (Inclusion Disease) 08/2022 - 01/2022
2	Primary Myelofibrosis (Myelosclerosis) 02/2022 - 01/2016
2	Anemia 02/2022 - 12/2021
2	Neoplasms (Cancer) 01/2020 - 01/2017
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016 - 01/2010
1	Hyperplasia 02/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Sarcoidosis (Schaumann Disease) 01/2020
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 12/2018
1	Multiple Myeloma 04/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2017
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2016
1	Essential Thrombocythemia 01/2016
1	Lymphoma (Lymphomas) 01/2016
1	Disease Progression 01/2016
1	Aspergillosis 07/2011
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2010
1	Sepsis (Septicemia) 12/2009

Drug/Important Bio-Agent (IBA)

1	Immunoglobulin G (IgG)IBA 08/2022
1	letermovirIBA 08/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	gilteritinibIBA 01/2022
1	purineIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	Pharmaceutical PreparationsIBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	5- ((1- (2,6- dichlorobenzyl)piperidin- 4- yl)methoxy)quinazoline- 2,4- diamineIBA 01/2019
1	EnzymesIBA 12/2018
1	RNA Precursors (Precursor, mRNA)IBA 12/2018
1	Proteasome InhibitorsIBA 04/2017
1	Bortezomib (Velcade)FDA Link 04/2017
1	Lenalidomide (CC 5013)FDA Link 04/2017
1	Immunomodulating AgentsIBA 04/2017
1	Thalidomide (Thalomid)FDA Link 04/2017
1	StilbenesIBA 01/2017
1	gnetin CIBA 01/2017
1	mogamulizumabIBA 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	CalreticulinIBA 01/2016
1	Janus Kinase 2IBA 01/2016
1	CCR4 ReceptorsIBA 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010
1	Gemtuzumab (Mylotarg)FDA Link 10/2009

Therapy/Procedure

5	Transplantation 08/2022 - 10/2009
2	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2016
2	Therapeutics 12/2018 - 07/2011
1	Cell Transplantation 08/2022
1	Blood Component Removal (Apheresis) 12/2021
1	Stem Cell Transplantation 07/2011
1	Cord Blood Stem Cell Transplantation 01/2010
1	Drug Therapy (Chemotherapy) 10/2009